Form 4: OraSure Technologies Director Shulkin Reports Share Transactions

Director David Shulkin reports acquisition and disposal of OraSure Technologies shares, including tax withholding and a grant of restricted shares.

Summary

• On May 13, 2025, Director David Shulkin disposed of 4,999 shares of OraSure Technologies common stock at a price of $2.6525 per share to cover tax liabilities associated with vesting restricted shares.
• On May 14, 2025, Shulkin acquired 71,017 restricted shares under the company's Stock Award Plan at $0.00.
• These restricted shares will vest fully on the earlier of May 14, 2026, or immediately before the company's 2026 Annual Meeting of Stockholders, ceasing if Shulkin voluntarily leaves the Board of Directors.
• Following these transactions, Shulkin beneficially owns 126,335 shares of OraSure Technologies common stock.

Sentiment

Score: 6

Explanation: Neutral sentiment as the transactions are routine and related to compensation and tax obligations. The grant of restricted shares is a positive sign of aligning director interests with the company's long-term success.

Positives

• The grant of restricted shares to a director aligns their interests with the long-term performance of the company.
• The vesting schedule encourages continued service on the Board of Directors.

Negatives

• The disposal of shares to cover tax liabilities could be perceived negatively, although it's a common practice.

Risks

• If the director leaves the board before the vesting date, the unvested shares will be forfeited.

Future Outlook

The director's holdings are tied to the company's future performance through the vesting of restricted shares, aligning their interests with shareholders until at least May 14, 2026, or the 2026 Annual Meeting.

Industry Context

Director share transactions are common and monitored to ensure compliance with insider trading regulations. Grants of restricted stock are a typical component of executive compensation packages in the technology industry.

Comparison to Industry Standards

• Stock grants to directors are a common practice in publicly traded companies, particularly in the tech sector, to align director interests with shareholder value.
• Vesting schedules, like the one described, are standard and often tied to continued service on the board.
• Companies like Abbott Laboratories and Danaher Corporation also use stock awards as part of their director compensation packages.

Stakeholder Impact

• Shareholders may view the director's increased stake in the company positively.
• The vesting schedule incentivizes the director to remain on the board, providing continuity.

Key Dates

Keywords

OraSure Technologies, Director, Share Transactions, Restricted Shares, Beneficial Ownership, Form 4, OSUR